Feasibility and efficacy of eight weeks Glecaprevir/Pibrentasvir to treat incarcerated viremic HCV patients: a case‐control study

Added 420 days ago (24.11.2020)
Authors: Vito Fiore, Roberto Ranieri, Serena Dell’Isola, Emanuele Pontali, Giorgio Barbarini, Tullio Prestileo, Daniele Marri, Giulio Starnini, Giovanni Sotgiu, Giordano Madeddu, Sergio Babudieri, SIMSPe Group
Read article